At a glance
ClinicalIndex Comparison RecordN/ACompleted· 145 enrolled
Drug / intervention
Natrox® Oxygen Wound Therapydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Controlled Multicentre Trial, Examining the Effect of Natrox® Oxygen Wound Therapy on the Healing Rate of Chronic Diabetic Foot Ulcers
In Brief
A clinical study evaluating Natrox® Oxygen Wound Therapy for Diabetic Foot Ulcer and Surgical Wound. Completed, enrolled 145 participants across 20 sites in 2 countries.
Detailed Summary
A Multicentre Randomized Controlled Trial to Investigate the Effect of Natrox Topical Oxygen Wound Therapy on the Healing rates of Diabetic Foot Ulcers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetic Foot Ulcer, Surgical Wound
CountriesPuerto Rico, United States
CollaboratorsSerenaGroup, Inc.
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedApr 2019
Enrollment StartJun 2019
Primary CompletionOct 2020
TodayJul 2026
First PostedApr 5, 2019
Enrollment StartJun 4, 2019
Primary CompletionOct 18, 2020
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 7.2 years ago
Interventions
Natrox® Oxygen Wound Therapydevice
A battery-operated device which delivers pure humidified oxygen to the wound bed through water electrolysis via a sterile oxygen delivery system.